Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

2 HOURS AGO - TheStreet

A Must Read - Share

AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop

NEW YORK (TheStreet) -- Shares of AstraZeneca Plc  are up 3.10% to $69.88 as Pfizer takeover talk grows even though the biopharmaceutical company reported lower first quarter earnings. First quarter profit excluding certain items declined 16% to $1.95 billion, or $1.17 a share, from $2.32 billion, or $1.41 a share. Analysts expected $1.21 a share, based on the average of 14 ...

Tags: AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop,  Astrazeneca Latest News

2 HOURS AGO - MarketWatch

A Must Read - Share

London Markets: AstraZeneca, Smith & Nephew push FTSE to 7-week high

The U.K.’s FTSE 100 index closes at its highest level in almost seven weeks, with Smith & Nephew and AstraZeneca leading stocks higher after well-received corporate news.

Tags: London Markets: AstraZeneca, Smith & Nephew push FTSE to 7-week high,  Astrazeneca Latest News

5 HOURS AGO - The Independent

A Must Read - Share

AstraZeneca boss Pascal Soriot guarded over potential Pfizer bid

The boss of AstraZeneca today refused to be drawn on whether the pharmaceuticals giant will be the target of a renewed takeover bid from US rival Pfizer.

Tags: AstraZeneca boss Pascal Soriot guarded over potential Pfizer bid,  Astrazeneca Latest News

6 HOURS AGO - New York Times

A Must Read - Share

AstraZeneca Plans Spin-Offs as Cancer Progress Fuels Bid Talk

AstraZeneca announced faster-than-expected progress of its experimental cancer drugs and plans to spin off billions of dollars of non-core assets as it staked a claim for independence following reports of bid interest from Pfizer.

Tags: AstraZeneca Plans Spin-Offs as Cancer Progress Fuels Bid Talk,  Astrazeneca Latest News

8 HOURS AGO - TheStreet

A Must Read - Share

European Stocks Rebound Amid M&A, Earnings Headlines

LONDON (The Deal) -- European stocks rebounded on Thursday amid mergers and acquisitions excitement and rash of first-quarter trading bulletins, while Asian indices were mixed after disappointing U.S. housing data. In London, the FTSE 100 was up 0.59% at 6,714.11. The DAX in Frankfurt climbed 0.68% to 9,609.36 and in Paris, the CAC 40 increased 0.82% to 4,487.47. In Germany, ...

Tags: European Stocks Rebound Amid M&A, Earnings Headlines,  Astrazeneca Latest News